The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response

Max Koeppel1, Simon J van Heeringen, Leonie Smeenk

  • 1Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.

Nucleic Acids Research
|December 2, 2008
PubMed

Insights

The tumor suppressor p53 regulates cellular fate. We identified IRF2BP2 as a new p53 target gene that influences cell survival and apoptosis by modulating p53

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The tumor suppressor p53 is crucial for cellular fate determination following genotoxic stress.
  • p53 regulates target genes to promote cell survival via repair or induce apoptosis.
  • The precise mechanisms dictating p53-mediated cellular outcomes remain incompletely understood.

Purpose of the Study:

  • To identify novel p53 target genes that influence cellular decisions after genotoxic insults.
  • To elucidate the role of interferon regulatory factor-2-binding protein-2 (IRF2BP2) in p53-mediated cellular responses.
  • To investigate how IRF2BP2 affects apoptosis and cell survival pathways regulated by p53.

Main Methods:

  • Analysis of IRF2BP2 expression in response to genotoxic agents (actinomycin D, doxorubicin) in cell lines with functional or non-functional p53.
  • Investigation of the interaction between IRF2BP2 and IRF2.
  • Assessment of IRF2BP2's impact on p53-mediated transactivation of p21 and Bax.
  • Functional studies involving IRF2BP2 overexpression and knockdown to evaluate effects on cellular stress response and apoptosis.

Main Results:

  • IRF2BP2 is identified as a direct p53 target gene, upregulated in a p53-dependent manner after actinomycin D treatment.
  • IRF2BP2 expression correlates with the downregulation of IRF2, a known growth-promoting factor.
  • Overexpression of IRF2BP2 impedes p53-mediated transactivation of p21 and Bax, reduces apoptosis induction after doxorubicin treatment, and impacts cellular stress response.
  • Knockdown of IRF2BP2 enhances p21 upregulation and accelerates apoptosis induction following doxorubicin and actinomycin D treatment.

Conclusions:

  • IRF2BP2 is a novel p53 target gene that plays a significant role in modulating p53-dependent cellular fate decisions.
  • IRF2BP2 acts as a negative regulator of p53-mediated apoptosis and influences the expression of key apoptosis-related genes like p21 and Bax.
  • IRF2BP2's function in regulating cellular stress responses and apoptosis provides new insights into the complex mechanisms governing cell survival and death pathways.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...